Sobi named UK’s top haemophilia company
Tops IPC Associates’ 2016 ranking
Read MoreSB-525 is being developed to treat haemophilia A
Read MoreEuropean regulators will investigate pricing of five oncology treatments
Read MoreBut would need rates to drop to 5 percent
Read MoreInnovate UK grant will help advance its manufacturing capabilities
Read MorePharmaTimes Media Ltd.
Mansard House
Church Road
Little Bookham
Leatherhead
Surrey KT23 3JG
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
F: +44 (0)20 7240 4479